07:00 , Mar 24, 2014 |  BC Week In Review  |  Company News

Azano, Manhattan Scientifics sales and marketing update

Manhattan Scientifics granted Azano exclusive, worldwide rights to commercialize NanoMRX Precision Nanoparticles. The technology uses non-toxic NanoMRX iron oxide nanoparticles and ultrasensitive magnetic detection to detect tumors one millionth the size detectable by X-rays and...
07:00 , Apr 1, 2013 |  BC Week In Review  |  Company News

Azano sales and marketing update

Azano launched its G-protein coupled estrogen receptor ( GPER ) agonist G-1 and antagonists G-15 and G-36 for research use. Azano said that the GPER has been reported to play a role in multiple diseases,...